Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety.

<h4>Background</h4>Lisinopril and losartan manufacturer labels recommend twice-daily dosing (BID) if once-daily (QDay) is insufficient to lower blood pressure (BP).<h4>Methods and results</h4>Retrospective cohort study of patients taking QDay lisinopril and losartan who experienced a dose-doubling (...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Catherine G Derington, Jordan B King, Thomas Delate, Sheila R Botts, Miranda Kroehl, David P Kao, Katy E Trinkley
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Public Library of Science (PLoS) 2020-01-01
coleção:	PLoS ONE
Acesso em linha:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0243371&type=printable
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!